Islet cell surface antibodies preferentially inhibit glucose-stimulated insulin release in vitro.
The effect of islet surface antibodies (ICSA) on in vitro insulin release was studied. Isolated rat islets were incubated in the presence of immunoglobulin preparations from patients with insulin-dependent and non-insulin-dependent diabetes mellitus (IDDM, NIDDM) and healthy subjects, and stimulated with D-glucose, L-arginine or tolbutamide. After incubation, the amount of insulin release from the rat islets was determined. The immunoglobulin preparations from 5 newly diagnosed IDDM patients who were positive for ICSA, and from 5 age-matched healthy subjects were examined. Even in the absence of complement or lymphocytes, immunoglobulin fractions positive for ICSA significantly inhibited low and high concentrations of glucose-stimulated insulin release compared with normal control (P less than 0.02), but had little influence on insulin release after stimulation with tolbutamide. Arginine-stimulated insulin release was almost the same in ICSA-positive immunoglobulin fractions and the control. Immunoglobulin fractions negative for ICSA either from four patients with recently diagnosed IDDM or from four newly diagnosed NIDDM patients had only negligible effect on insulin release after stimulation with glucose. These results suggest that ICSA in IDDM patients, even in the absence of complement or lymphocytes, may preferentially interfere with the mechanisms of glucose-stimulated insulin release in the pancreatic B cells.
Kitagawa
Y
Y
First Department of Internal Medicine, Kyoto Prefectural University of Medicine, Japan.
Kanatsuna
T
T
Kajiyama
S
S
Nakamura
N
N
Nakamura
Y
Y
Kano
Y
Y
Nakano
K
K
Kondo
M
M
Ludvigsson
J
J
D000293:Adolescent; D000328:Adult; D000818:Animals; D001120:Arginine / Q000494:pharmacology; D001323:Autoantibodies / Q000276:immunology*; D002648:Child; D003920:Diabetes Mellitus / Q000276:immunology*; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology; D005260:Female; D005947:Glucose / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D051381:Rats; D012016:Reference Values; D014044:Tolbutamide / Q000494:pharmacology
D001323:Autoantibodies; D007328:Insulin; C024211:islet cell antibody; D001120:Arginine; D014044:Tolbutamide; D005947:Glucose